Recurrent vulvovaginal candidiasis.
Sobel JD.
Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9.
Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy.
Sun Z, Ge X, Qiu B, Xiang Z, Jiang C, Wu J, Li Y.
Front Cell Infect Microbiol. 2023 Feb 3;13:1123026. doi: 10.3389/fcimb.2023.1123026. eCollection 2023.
Global burden of recurrent vulvovaginal candidiasis: a systematic review.
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R.
Lancet Infect Dis. 2018 Nov;18(11):e339-e347. doi: 10.1016/S1473-3099(18)30103-8. Epub 2018 Aug 2.
Vulvovaginal candidiasis-an overview of current trends and the latest treatment strategies.
Bhosale VB, Koparde AA, Thorat VM.
Microb Pathog. 2025 Mar;200:107359. doi: 10.1016/j.micpath.2025.107359. Epub 2025 Feb 5.
The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis.
Zahedifard T, Khadivzadeh T, Rakhshkhorshid M.
Ethiop J Health Sci. 2023 Sep;33(5):881-890. doi: 10.4314/ejhs.v33i5.18.
Recurrent vulvovaginal candidiasis.
Blostein F, Levin-Sparenberg E, Wagner J, Foxman B.
Ann Epidemiol. 2017 Sep;27(9):575-582.e3. doi: 10.1016/j.annepidem.2017.08.010. Epub 2017 Aug 15.
Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, López-Barcenas A, Fabbrocini G, Bardhi B, Sinani A, Sánchez-Blanco E, Arenas-Guzmán R, Hernandez-Castro R.
Colloids Surf B Biointerfaces. 2019 Feb 1;174:110-125. doi: 10.1016/j.colsurfb.2018.11.011. Epub 2018 Nov 7.
Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
MacAlpine J, Lionakis MS.
Cell Host Microbe. 2024 Oct 9;32(10):1654-1667. doi: 10.1016/j.chom.2024.08.018.
Vulvovaginal Candidiasis.
[No authors listed]
J Midwifery Womens Health. 2024 May-Jun;69(3):443-444. doi: 10.1111/jmwh.13650. Epub 2024 May 13.
Vulvovaginal candidiasis.
Marrazzo J.
BMJ. 2002 Sep 14;325(7364):586. doi: 10.1136/bmj.325.7364.586.
